Stephanie Lovell - 22 Nov 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
22 Nov 2022
Net transactions value
-$139,602
Form type
4
Filing time
23 Nov 2022, 15:30:54 UTC
Previous filing
16 Jun 2022
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $181,716 +3,800 $47.82 3,800 22 Nov 2022 Direct
transaction TMDX Common Stock Sale $220,286 -3,800 -100% $57.97 0 22 Nov 2022 Direct
transaction TMDX Common Stock Options Exercise $28,886 +1,100 $26.26 1,100 22 Nov 2022 Direct
transaction TMDX Common Stock Sale $63,844 -1,100 -100% $58.04 0 22 Nov 2022 Direct
transaction TMDX Common Stock Options Exercise $270,518 +5,657 $47.82 5,657 23 Nov 2022 Direct
transaction TMDX Common Stock Sale $336,592 -5,657 -100% $59.50 0 23 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3,800 -21% $0.000000 14,200 22 Nov 2022 Common Stock 3,800 $47.82 Direct F1
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1,100 -49% $0.000000 1,150 22 Nov 2022 Common Stock 1,100 $26.26 Direct F1
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5,657 -40% $0.000000 8,543 23 Nov 2022 Common Stock 5,657 $47.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.